Supernus Pharmaceuticals, Inc. (LON:0LB2)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,358	1,595	1,241	1,600	1,145	971
Market Cap Growth	69.60%	28.49%	-22.44%	39.74%	17.96%	3.33%
Enterprise Value	1,988	1,303	1,098	1,534	833	746
Last Close Price	41.51	29.01	23.10	29.31	22.93	18.71
PE Ratio	50.10	27.03	1201.42	31.76	29.03	10.44
PS Ratio	4.86	3.02	2.60	2.89	2.68	2.55
PB Ratio	3.04	1.93	1.72	2.18	1.90	1.78
P/TBV Ratio	6.94	5.03	7.73	28.90	-	4.38
P/FCF Ratio	17.38	11.66	14.30	16.56	12.40	9.84
P/OCF Ratio	17.27	11.61	14.23	16.51	12.20	9.58
EV/Sales Ratio	3.96	2.47	2.30	2.77	1.95	1.96
EV/EBITDA Ratio	17.93	11.51	14.23	14.10	10.06	5.26
EV/EBIT Ratio	51.06	26.59	104.31	40.53	14.18	5.80
EV/FCF Ratio	14.65	9.53	12.65	15.88	9.01	7.56
Debt / Equity Ratio	0.03	0.03	0.05	0.51	0.54	0.59
Debt / EBITDA Ratio	0.22	0.22	0.37	3.13	3.55	2.17
Debt / FCF Ratio	0.17	0.20	0.38	3.87	3.52	3.24
Asset Turnover	0.49	0.50	0.41	0.39	0.36	0.39
Inventory Turnover	1.36	1.18	0.99	0.98	1.12	1.40
Quick Ratio	2.32	2.04	1.38	0.91	1.55	2.30
Current Ratio	2.58	2.35	1.70	1.07	1.91	2.57
Return on Equity (ROE)	6.38%	7.55%	0.15%	7.13%	6.85%	18.94%
Return on Assets (ROA)	2.39%	2.90%	0.56%	1.68%	3.11%	8.24%
Return on Capital (ROIC)	3.08%	3.77%	0.73%	2.20%	4.08%	10.08%
Return on Capital Employed (ROCE)	4.70%	5.70%	1.40%	4.50%	5.80%	13.90%
Earnings Yield	2.00%	3.70%	0.08%	3.15%	3.45%	9.58%
FCF Yield	5.75%	8.58%	6.99%	6.04%	8.07%	10.16%
Buyback Yield / Dilution	-3.11%	-0.81%	10.01%	-13.47%	-1.24%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.